This webinar will cover the following topics: 

  • How to adjudicate multiple stakeholder perspectives in first in human studies with constrained resources
  • More dose levels, fewer patients, and the importance of bioanalysis
  • Multiple hypotheses, multiple procedures: A seductive siren of complexity or a necessity of innovation?
  • Easy to say, difficult to do: “Translational research” in orphan disease drug development